PASAY CITY, Metro Manila- In the recent “Rallying Communicators for Science, Technology, and Innovation in Health” pre-conference session of the 11th Philippine National Health Research System (PNHRS), communication expert Dr. Clarissa David talked about ways to communicate health research and engage the public.
PASAY CITY, Metro Manila- To further improve their strategies on research utilization, the regional consortia of the Philippine National Health Research System (PNHRS) gathered yesterday in a session at Hotel Jen Manila.
The session entitled “Rallying Communicators for Science, Technology, and Innovation in Health” aims to gather members for the Society of Health Research Communicators (SHARE), a new program of the System to ensure that research contributes to evidence-informed health policies and actions.
SHARE is a community of communicators who share health research stories, advocacies, and local and national initiatives. The community will reinforce the research dissemination activities of the regional consortia of PNHRS.
The first part of the session was allotted for discussions wherein three communication and health research experts were invited to guide the participants namely Dr. Clarissa David of the University of the Philippines (UP) College of Mass Communication, Dr. Mary Ann Lansang of the UP College of Medicine, and Dr. Iris Thiele Isip-Tan of the UP Manila Medical Informatics Unit.
In the afternoon, members of the regional consortia engaged in a discussion to form, gather, and sustain the SHARE community.
In her welcome remarks, Ms. Merlita Opeña, Philippine Council for Health Research and Development (PCHRD) Division Chief, stressed that research utilization is an important process in the Philippine National Health Research System (PNHRS).
“I would like to emphasize that research utilization focuses on the impact or benefit of knowledge to our stakeholders. It is about what the people will gain from the research result or how they will make use of the knowledge or information.” Ms. Opeña explained.
The “Rallying Communicators for Science, Technology, and Innovation in Health” is part of the 11th Philippine National Health Research System (PNHRS) Week celebration. PCHRD is the lead coordinator of the System.
Source: PCHRD Website
PASAY CITY, Metro Manila- The country’s health research community, headed by the Philippine Council for Health Research and Development (PCHRD), will celebrate the 11th Philippine National Health Research System (PNHRS) Week on 24-25 August 2017 at Philippine International Convention Center.
A small green sponge discovered in dark, icy waters of the Pacific off Alaska could be the first effective weapon against pancreatic cancer, researchers said Wednesday.
Pancreatic cancer, with particularly aggressive tumors, is notoriously difficult to treat.
“One would never have imagined looking at this sponge that it could be miraculous,” Bob Stone, a researcher at the NOAA Alaska Fisheries Science Center, said in a briefing by phone.
Stone discovered the sponge, dull in color, called “Latrunculia austini” in 2005 while on a seabed exploration expedition in Alaska.
It lives on rocks in patches at depths of 230-720 feet (70-219m).
Lab testing has shown that several molecules in this sponge selectively destroy pancreatic cancer cells, said Mark Hamann, a University of South Carolina researcher working with Fred Valeriote of the Henry Ford Cancer Institute in Detroit.
“This is undoubtedly the most active molecule against pancreatic cancer that we see,” said Hamann. “Although there is still much work to be done, it marks the first key step in the discovery and process of developing a treatment,” he said.
Pancreatic cancer progresses slowly, a circumstance which leaves patients in a tough position as late diagnosis means little chance for successful treatment.
Patients’ chances of survival at five years for this tumor are only 14%, according to the American Cancer Society.
“I’ve looked at 5,000 sponge extracts over the last two decades,” Valeriote said. “In terms of this particular pattern of pancreatic and ovarian cancer selective activity, we’ve only seen one (other) sponge with such activity, and that was one collected many years ago in Indonesia.”
In the United States, 53,670 new cases of pancreatic cancer will be diagnosed in 2017 and more than 43,000 people will die.
Source: Manila Bulettin- Published